Sight Sciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Sight Sciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- SGHT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001531177
Board of directors
-
Brenda Jane Larsen-Becker · DirectorSince 2023
-
Catherine Mazzacco · DirectorSince 2023
-
David Badawi · Director · Chief Technology OfficerSince 2023
-
Donald Zurbay · DirectorSince 2023
-
Erica J. Rogers · DirectorSince 2023
-
Gerhard F. Burbach · DirectorSince 2025
-
Paul Badawi · Director · President and CEOSince 2023
-
Staffan Encrantz · DirectorSince 2023
-
Tamara Fountain · DirectorSince 2023
-
Valeska Schroeder · DirectorSince 2023
Chief executives
Paul Badawi
· President and CEO
Dates unknown
Board connections
5 of this board's directors also sit on 6 other boards.
- via Gerhard F. Burbach
- via Erica J. Rogers
- via Donald Zurbay
- via Catherine Mazzacco
- via Donald Zurbay
- via Tamara Fountain
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $184,799
- 2 purchases by 1 insider
- Sold, last 12 months
- $2,413,660
- 38 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Rashid Kashif Officer (Chief Legal Officer) | Grant or award | +181,818 | — | — |
| Jul 6, 2026 | David Badawi Director, Officer (Chief Technology Officer) | Open-market sale | −7,418 | $5.51 | $40,858 |
| Jul 6, 2026 | HAYDEN JEREMY B. Officer (Chief Legal Officer) | Open-market sale | −12,733 | $5.51 | $70,133 |
| Jul 2, 2026 | Bauerlein Alison Officer (Chief Operating Officer) | Open-market sale | −24,184 | $5.36 | $129,626 |
| Jul 2, 2026 | Rodberg James Officer (Chief Financial Officer) | Open-market sale | −6,902 | $5.36 | $36,995 |
| Jul 1, 2026 | Paul Badawi Director, Officer (President and CEO), 10% owner | Open-market sale | −28,684 | $5.42 | $155,467 |
| Jul 1, 2026 | Taylor Brenton Officer (EVP, Operations & R&D) | Open-market sale | −2,829 | $5.42 | $15,333 |
| Jun 10, 2026 | Staffan Encrantz Director, 10% owner | Open-market purchase | +14,100 | $4.88 | $68,808 |
| Jun 4, 2026 | Tamara Fountain Director | Grant or award | +28,261 | — | — |
| Jun 4, 2026 | Staffan Encrantz Director, 10% owner | Grant or award | +28,261 | — | — |
| Jun 4, 2026 | Gerhard F. Burbach Director | Grant or award | +28,261 | — | — |
| Jun 4, 2026 | Donald Zurbay Director | Grant or award | +28,261 | — | — |
| Jun 4, 2026 | Catherine Mazzacco Director | Grant or award | +28,261 | — | — |
| May 18, 2026 | Bauerlein Alison Officer (Chief Operating Officer) | Open-market sale | −12,728 | $5.12 | $65,167 |
| Apr 6, 2026 | Rodberg James Officer (Chief Financial Officer) | Open-market sale | −7,231 | $3.55 | $25,670 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.